Skip to content

Trending News

What Just Happened
5 years agoOptimizeRx Announces Agreement with a Top Pharmaceutical Manufacturer to Use its Evidence-Based Physician Engagement to Solve Lapse in Medical Coverage Barrier for Patients – Stockhouse 5 years agoOM1 Launches Multiple Sclerosis Registry with More than 20000 Patients Prospectively Followed with Deep Clinical Data – Markets Insider 5 years agoReal-World Evidence And Its Use In Advertising Of Medicinal Products In The EU And US – Media, Telecoms, IT, Entertainment – Worldwide – Mondaq News Alerts 5 years agoNational Evaluation System for health Technology Coordinating Center Adds Clinical Laboratory and Patient Engagement Expertise to Governing Committee – Business Wire 5 years agoAbnormal temperatures linked to climate change cause over 740,000 deaths annually in India
Saturday, Mar 7, 2026
Primary Menu
  • Categories
    • Real World Research (RWR)
    • RWD Sources
    • Movers and Shakers
    • RWE – Real World Evidence
    • Health Tech
    • Medical Devices
    • RWR & COVID 19
    • Regulatory
    • Oncology
    • Mental Health
    • Schrödinger’s Donkey
    • Decentralised Trials
    • Recently Released
  • Editorials
  • RWR
  • Newsfeed
  • FAQ
  • ABOUT
    • About RWR News
    • About the Authors
    • RWR News Editorial Policy
  • RESOURCES
    • Phoenix RWR Consulting
    • RedBird Reg Intel Tools
    • RWR Study Master File

Tag: Clinical medicine

  • Home
  • Clinical medicine
  • Page 4
Category:
  • Recently Released
  • RWE - Real World Evidence

Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program – MD Linx

EXPERT NOTES: CONTEXT:  Peer Reviewed Data, RWE of Effectiveness of Cabozantinib IMPACT:  In the largest real-world study to date, cabozantinib was effective in unselected, heavily pretreated patients with mRCC. Initiation Continue Reading

Posted On : January 29, 2021 Published By : stuart.mccully
Category:
  • Decentralised Trials
  • Recently Released

Contributed: Trials and tribulations – the new world of decentralized trials – Mobihealth News

EXPERT NOTES: CONTEXT:  Decentralized Clinical Trials IMPACT:  Enabling technology for ‘Decentralized Clinical Trials’ a.k.a ‘Virtual Trials’ Time Taken = 2 mins QUOTES FROM SOURCE: 1. “As mentioned earlier, COVID-19 has Continue Reading

Posted On : January 29, 2021 Published By : stuart.mccully
Category:
  • Real World Research (RWR)
  • Recently Released
  • Regulatory
  • RWE - Real World Evidence
  • RWR & Regulators

Japan to use data from outside clinical trials in drug approvals – Nikkei Asia

Quick Notes: CONTEXT:  Japan, Real-World Data IMPACT:  Acceptability of RWD in Regulatory Submissions Time to Read = 2 mins Quotes from Source: 1. “TOKYO — Japan’s health ministry will issue Continue Reading

Posted On : January 29, 2021 Published By : stuart.mccully
Category:
  • Pharmacovigilance (post-approval)
  • Recently Released

News: Human medicines: highlights of 2020

Quick Notes: *Within the report the “conditional marketing authorisations” and “monitoring in real-life” are the “go to” section to see what the post-authorisation obligations were and what the EMA is Continue Reading

Posted On : January 29, 2021 Published By : stuart.mccully

Posts navigation

Newer posts

XKCD Mental Break

Coffee Break Cartoon XKCD

We don’t spam! Read more in our privacy policy

Check your inbox or spam folder to confirm your signup and download

Copyright RedBird 2021
Theme: Royal Magazine by ThemeinWP
  • Cookie Policy (EU)
  • Privacy Statement (EU)
  • Impressum
  • Cookie Policy (UK)
  • Privacy Statement (UK)
  • Cookie Policy (US)
  • Cookie Policy (CA)
  • Privacy Statement (CA)
  • Disclaimer
  • Privacy Statement (US)